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Abstract 
Background 
Genetic selection for host resistance offers a desirable complement to chemical treatment to 
control infectious disease in livestock. Quantitative genetics disease data frequently originate 
from field studies and are often binary. However, current methods to analyse binary disease 
data fail to take infection dynamics into account. Moreover, genetic analyses tend to focus on 
host susceptibility, ignoring potential variation in infectiousness, i.e. the ability of a host to 
transmit the infection. This stands in contrast to epidemiological studies, which reveal that 
variation in infectiousness plays an important role in the progression and severity of 
epidemics. In this study, we aim at filling this gap by deriving an expression for the 
probability of becoming infected that incorporates infection dynamics and is an explicit 
function of both host susceptibility and infectiousness. We then validate this expression 
according to epidemiological theory and by simulating epidemiological scenarios, and 
explore implications of integrating this expression into genetic analyses. 
Results 
Our simulations show that the derived expression is valid for a range of stochastic genetic-
epidemiological scenarios. In the particular case of variation in susceptibility only, the 
expression can be incorporated into conventional quantitative genetic analyses using a 
complementary log-log link function (rather than probit or logit). Similarly, if there is 
moderate variation in both susceptibility and infectiousness, it is possible to use a logarithmic 
link function, combined with an indirect genetic effects model. However, in the presence of 
highly infectious individuals, i.e. super-spreaders, the use of any model that is linear in 
susceptibility and infectiousness causes biased estimates. Thus, in order to identify super-
spreaders, novel analytical methods using our derived expression are required. 
Conclusions 
We have derived a genetic-epidemiological function for quantitative genetic analyses of 
binary infectious disease data, which, unlike current approaches, takes infection dynamics 
into account and allows for variation in host susceptibility and infectiousness. 
Background 
Infectious diseases constitute the number one threat to livestock production, with potential 
devastating implications for food security and human health. With the rapid accumulation of 
data on the genetic regulation of host responses to infectious pathogens, the drive towards 
strategies that control genetic disease is gaining momentum. Genetic approaches to combat 
infectious disease tend to focus on improving host resistance, i.e. the ability of a host to block 
pathogen entry or to counteract pathogen replication within the host. However, despite 
enormous breakthroughs in genomics, estimating genetic parameters for disease resistance 
has proven considerably more challenging than analysis of production traits, and this has 
hampered the incorporation of disease traits into breeding programmes. These challenges 
partly arise because disease resistance is not a trait that is directly measurable but relies on 
observable proxies. Due to the requirement of large sample sizes for quantitative genetic 
analyses, such proxies are often obtained from field data, which are typically binary, 
indicating whether an individual has become infected or not [1]. 
Current quantitative genetic methods analyse binary infectious disease data essentially by 
contrasting the set of individuals diagnosed as infected to those diagnosed as non-infected, 
assuming that the observed phenotypic differences represent differences in host resistance to 
the pathogens under consideration [2]. However, the corresponding statistical models, such as 
threshold or logit models, entail several intrinsic assumptions that are unrealistic in the case 
of infectious disease: First, the observations (e.g. diseased / not diseased) are assumed to be 
accurate but in reality, the diagnostic tools that are used in the field rarely have complete 
sensitivity or specificity, i.e. there is a considerable chance for misclassification of 
individuals as healthy or diseased. Second, it is assumed that exposure to infectious 
pathogens of individuals that share the same environment is (a) equal between individuals, 
(b) constant over time and (c) purely environmental. However, in large groups with a non-
uniform contact structure, there may be substantial heterogeneity in exposure at any given 
time. Thus, an individual classed as healthy may have indeed greater resistance, or could 
simply be misdiagnosed, or may not yet have come in contact with the infectious agents. 
Furthermore, for infectious diseases transmitted by direct contact, the disease status of an 
individual is not just the expression of its own resistance in a constant infectious 
environment. Instead infections result from dynamic interactions between susceptible and 
infected individuals, and genetic variation may be inherent to all such interactions. As the 
number of infected individuals in a population changes throughout the time course of a 
disease outbreak, exposure will change as well. Lastly, exposure depends on how infectious 
the infected individuals are, which may differ between individuals, e.g. due to different 
shedding patterns of infectious material or different durations of shedding. Thus, not only 
host resistance but also host infectiousness, i.e. the ability of a host to transmit an infection, 
may display substantial host genetic variation. 
All of the above characteristics that are inherent to natural disease outbreaks are likely to 
affect estimates of genetic parameters for disease traits. Indeed, we have previously 
demonstrated that conventional quantitative genetics models fail to capture host genetic 
variation in infectiousness, if present [3,4]. Furthermore, theoretical work has established that 
imperfect diagnostics and incomplete or variable exposure produce a downward bias in 
estimates of heritability and of SNP (single nucleotide polymorphism) effects, and affect 
inferences about modes of inheritance of SNP effects for disease resistance [1,5]. This theory 
is empirically supported by comparing results from recent field and challenge experiments 
that aimed at estimating genetic parameters and at identifying genetic markers for the 
resistance of pigs to the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) 
[6,7]. Both these studies included approximately 1200 animals, but whereas infection resulted 
from natural transmission dynamics in the field studies [7], the challenge experiment infected 
all animals with the same dose of a particular PRRSV strain [6], thus excluding the various 
sources of heterogeneity in exposure outlined above. In accordance with theory, heritability 
estimates for viraemia were considerably lower based on field data than from challenge data 
(0.096 vs. 0.31) and the challenge study found a major QTL for disease resistance that had 
not been identified in the field data. Thus, both theory and experimental evidence imply that, 
in order to use data from natural disease outbreaks to determine the host genetic influence 
underlying infectious disease, current quantitative genetics methodology must be modified to 
take transmission dynamics into account. In quantitative genetic analyses, it is customary to 
assume that binary data is the realisation of a probability. Thus an important step is to 
identify the probability function that links the epidemiological parameters of interest, such as 
susceptibility and infectiousness, to the probability of becoming infected. 
Therefore, the aim of this study was to derive an analytical expression for the probability of 
an individual to become infected within a given time period. We demonstrate how this can be 
achieved by integrating fundamental principles of epidemiology into the quantitative genetics 
framework. We then validate this analytical expression by comparing it with established 
theory in the case of homogeneous populations and by using simulated disease data generated 
for a range of epidemiological scenarios in genetically heterogeneous populations. Finally, 
we examine the implications for implementing this probability function into quantitative 
genetic analyses. 
Methods 
Epidemiological principles and approaches 
The study of infectious diseases typically falls within the realm of epidemiology. A key 
measure in epidemiology is the basic reproductive ratio R0, defined as the expected number 
of secondary infections that one infectious individual causes in an otherwise susceptible 
population [8]. Efforts for epidemiological control of infections are targeted to reduce R0, 
ideally to a value below one, because if R0 is less than one, infection is unlikely to spread and 
expected to die out. The higher R0 is, the greater are the risk and severity of epidemics [8]. 
This key definition points to two important host characteristics that control the spread of 
infection: first, the susceptibility of non-infected individuals, i.e. the propensity of becoming 
infected upon contact with an infectious individual or substance, and second, the 
infectiousness of the infected individuals, i.e. the ability of an infected individual to transmit 
the infection. As stipulated by Lloyd-Smith et al. [9], for diseases transmitted by direct 
contact, infectiousness (or, using their terminology, individual reproductive number with 
population mean R0) can be regarded as the product of three factors: c, the rate at which an 
infectious individual comes into contact with others in the population; f, the probability that 
the disease is transmitted to a susceptible individual, given contact; and D, the duration of the 
infectious period. All three components may harbour exploitable genetic variation. 
Epidemiologists rely heavily on mathematical models of transmission dynamics to predict the 
outcome of control strategies. For instance, using a conventional compartmental SIR model 
that describes the transition of individuals between the Susceptible (S), Infected (I) and 
Recovered or Removed (R) compartment, the change in disease prevalence is described by 
)()()( tItItS
dt
dI γβ −=  with parameters β (transmission coefficient) and γ (recovery rate) [10]. 
This differential equation represents infection as a dynamic process that arises from the 
interaction between susceptible and infected individuals (through the use of a multiplicative 
term in S and I). The transmission coefficient β is the product of the contact rate and the 
probability that the contact between an infectious and a susceptible individual results in a 
successful transmission [10], and thus, depends on the susceptibility of the susceptible 
individual and the infectiousness of the infectious individual. Furthermore, for SIR models 
with constant population size, the probability P(t) of an initially susceptible individual to 
become infected within a time period t is given by 
𝑃(𝑡) = 1 − e−Λ(𝑡) (1) 
Where Λ(t) =  R𝟎 ∗ R(t)/S0  denotes the force of infection, i.e. the rate at which susceptible 
individuals become infected, and R(t) and S0 are the number of recovered individuals at time t 
and the initial number of susceptible individuals, respectively [10]. 
Although epidemiologists acknowledge that there may be variation between individuals in 
both susceptibility and infectivity e.g. [11], classical epidemiology assumes homogeneity 
between individuals or within subgroups of individuals and therefore excludes the concept of 
host genetics. However, this gap has been shown to have a profound impact on the prediction 
of disease risk and prevalence, e.g. [12-14]. In particular, recent field studies have elucidated 
the important role of super-spreaders, the small proportion of highly infectious individuals 
responsible for the majority of transmission events, on the occurrence and severity of disease 
outbreaks across a range of diseases [15-18]. Note that super-spreaders confer host 
heterogeneity in infectiousness, not in resistance. Therefore, understanding and controlling 
heterogeneity in infectiousness, i.e. not only resistance, is now recognized as an important 
measure to control disease [16]. However, to date, the genetic contribution of the host to this 
variation in infectiousness is unknown since genetic analyses tend to focus on disease 
resistance and, as demonstrated in [3] and [4], fail to fully capture host genetic variation in 
infectiousness, if present, from binary disease data. 
Derivation of a genetic-epidemiological probability function 
Binary disease phenotypes can be considered as the realization of a probability of having the 
observed disease phenotype. In this section, we will extend the epidemiological equation (1) 
for the (cumulative) probability of an individual to become infected by a time t for a 
heterogeneous host population with variation in both host susceptibility and infectiousness. 
For this purpose, we define fk as the probability of an infectious individual k to infect a 
susceptible individual with unit susceptibility following contact, and gj as the susceptibility of 
an individual j following contact with an infectious individual of unit infectivity. 
Furthermore, we define the indicator Xf,k(t) to be equal to 1 if k is infectious at time t and to 0 
otherwise. Then, the probability of a susceptible individual j of becoming infected following 
contact with individual k at time t is the product gj Xf,k(t) fk. Let cjk be the expected number of 
contacts in a unit time interval between individuals j and k. Thus, following the same 
approach as in [10], for a susceptible individual not to become infected in a unit time interval, 
none of the contacts must result in infection. In other words, the probability of a susceptible 
individual j to avoid getting infected in a unit time interval is equal to 
� �1 − 𝑔𝑗𝑋𝑓,𝑘(𝑡)𝑓𝑘�𝑐𝑗𝑘𝑛
𝑘=1,𝑘≠𝑗 . (2) 
The probability Pj*(δt) of a susceptible individual j to become infected during a sufficiently 
short time interval [t, t + δt] during which the infection status of infectious individuals does 
not change is therefore, 
𝑃𝑗
∗(𝛿𝑡) = 1 − � � �1 − 𝑔𝑗𝑋𝑓,𝑘(𝑡)𝑓𝑘�𝑐𝑗𝑘𝑛
𝑘=1,𝑘 ≠𝑗 �
𝛿𝑡 . (3) 
Let Pj(t) be the probability of individual j, which was susceptible at time zero, to have 
become infected by time t. Then for a small time-step δt, 
𝑃𝑗(𝑡 + 𝛿𝑡) = 𝑃𝑗∗(𝛿𝑡)(𝟏 − 𝑃𝑗(𝑡)) + 𝑃𝑗(𝑡). (4) 
Note, that this equation may encompass single and repeated infections (e.g. infected, 
recovered and re-infected) within the time interval from 0 to t. Rearranging the above 
equation, dividing by δt and taking the limit δt → 0 leads to 
𝑑𝑃𝑗(𝑡)
𝑑𝑡
 =  lim
𝛿𝑡→0
𝑃𝑗
∗(𝛿𝑡)
𝛿𝑡
�1 − 𝑃𝑗(𝑡)�. (5) 
Note that the expression for Pj∗(δt) above can be written as 
𝑃𝑗
∗(𝛿𝑡) =
1 − exp� 𝛿𝑡 � 𝑐𝑗𝑘𝑛
𝑘=1,𝑘≠ 𝑗 ln�1 − 𝑔𝑗𝑋𝑓,𝑘(𝑡)𝑓𝑘�� .  (6) 
Using the power series expansion of the exponential function, and dividing by δt and taking 
the limit δt → 0, leads to 
lim
δt→ 𝟎 𝑃𝑗∗(𝛿𝑡)𝛿𝑡  =  � cjkn
k=𝟏,k≠ j ln(1 − gj Xf,k(t)fk)  
≈  gj � cjk  Xf,k (t)fk)n
k=𝟏,k≠ j , 
(7) 
using the approximation ln(1 − x) ≈ − x for small x. Substituting this last expression into the 
differential equation (5) yields 
𝑑𝑃𝑗(𝑡)
𝑑𝑡
 =  𝑔𝑗  � 𝑐𝑗𝑘𝑛
𝑘=1,𝑘≠ 𝑗 𝑋𝑓,𝑘(𝑡)𝑓𝑘 (1 − 𝑃𝑗(𝑡)).  (8) 
Now, define 
Λ𝑗(𝑡): = � � 𝑔𝑗 � 𝑐𝑗𝑘𝑛
𝑘=1,𝑘≠ 𝑗 𝑋𝑓,𝑘(𝑢 )𝑓𝑘�𝑑𝑢.𝑡0    (9) 
so that 
𝑑𝑃𝑗(𝑡)
𝑑𝑡
 = 𝑑Λ𝑗(𝑡)
𝑑𝑡
 (1 − 𝑃𝑗(𝑡)). (10) 
Multiplying both sides of (10) by 𝑒Λ𝑗(𝑡) and collecting all terms to the left hand side leads to 
𝑑
𝑑𝑡
� 𝑒Λ𝑗(𝑡)𝑃𝑗(𝑡) −  𝑒Λ𝑗(𝑡)�  =  0, (11) 
or 
𝑒Λ𝑗(𝑡) �𝑃𝑗(𝑡) − 1� =  𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡. (12) 
Hence, the solution of the differential equation (10) is 
𝑃𝑗(𝑡) = 1 + �𝑃𝑗(0) − 1�𝑒−Λ𝑗(𝑡). (13) 
The probability Pj(0) can be estimated as the prevalence at the beginning of an observation 
period. For simplicity, however, from now on we will assume that 𝑃𝑗(0) = 0 and hence, 
𝑃𝑗(𝑡) = 1 − 𝑒−Λ(𝑡). (14) 
Note that the quantity Λj(t) defined above can be written as 
Λ𝑗(𝑡) =  𝑔𝑗 � 𝑐𝑗𝑘𝑛
𝑘=1,𝑘≠ 𝑗 𝑓𝑘𝐷𝑘(𝑡). (15) 
where 𝐷𝑘(𝑡) denotes the duration of time within the interval [0,t] during which individual k is 
infectious. Thus, if k has not become infected by time t, 𝐷𝑘(𝑡)  =  0, otherwise 
𝐷𝑘(𝑡) = �� 𝑚𝑖𝑛�𝑡𝐸𝑖 , 𝑡� −  𝑡𝑆𝑖�𝑚
𝑖=1
,   
 where m denotes the number of times that individual k got infected during [0,t] and 𝑡𝑆𝑖 and 𝑡𝐸𝑖 
denote the start and end of the corresponding infectious periods, respectively. 
Function validation 
Two forms of validation of the above derived probability function given by equation (14) 
with Λj(t) defined in (15) were carried out. First, we assessed whether in the extreme case of 
zero heterogeneity in susceptibility and infectiousness, the derived function is consistent with 
existing epidemiological theory. Second, the function was validated with binary disease data 
(infected or not infected) generated by simulated stochastic epidemics in closed genetically 
heterogeneous populations of constant size, as described in detail in [3,4]. Two methods were 
chosen to illustrate this second validation: (i) a direct comparison of the probability of 
infection predicted by the derived analytical expressions (14) and (15) with the proportion of 
individuals that became infected in the simulations, and (ii) Receiver Operating Characteristic 
(ROC) curves. A ROC curve is a widely used graphical representation of the ability of a 
predictor to discriminate between cases and controls by plotting the True Positive Rate (TPR 
= sensitivity) against the False Positive Rate (FPR = 1-specificity) [19]. Here, the ROC 
curves plot the proportion of infected individuals that have an estimated probability of 
infection greater than a given threshold (True Positives) against the proportion of non-
infected individuals that have an estimated probability of infection greater than this same 
threshold (False Positives). Thus, the Area Under this Curve (AUC) describes the probability 
of correctly ranking any infected/non-infected pair of individuals using the derived 
probability function. Thus, if the analytical prediction is entirely unrelated to the probability 
of becoming infected in the simulations, then individuals would be classified at random and 
the AUC would be equal to 0.5. However, if our function accurately describes the probability 
of becoming infected in the simulations, then the AUC would be close but not equal to 1, due 
to the stochastic nature of the simulations. 
The stochastic epidemiological model used for validation simulates disease progression in 
isolated groups of n individuals and provides the disease status of individuals (infected / not 
infected) over time as output. The epidemic was simulated as a Poisson process, starting with 
one randomly chosen infected individual per group. The times at which subsequent infection 
and recovery events occurred and which individuals were affected were determined by the 
pairwise transmission parameters 𝛽𝑗𝑘(𝑡) and by the recovery rates 𝛾𝑗(𝑡), respectively, as 
outlined below. It was assumed that infected individuals became immediately infectious and 
remained infectious until they recovered. No transmission was assumed between groups. 
Individual variation in host susceptibility and infectiousness was first incorporated into the 
model by assigning for each individual j its own level of susceptibility gj and infectivity fj. 
The dynamic, pairwise transmission parameter βjk(t) was then calculated as: 
𝛽𝑗𝑘(𝑡) = −𝑐𝑗𝑘𝑙𝑛�1 − 𝑋𝑔,𝑗(𝑡)𝑔𝑗𝑋𝑓,𝑘(𝑡)𝑓𝑘�, (16) 
as derived in [3]. Thus, in line with standard epidemiological theory 𝛽𝑗𝑘(𝑡) encapsulates the 
contact rate and the transmission probability. To reflect whether susceptibility and infectivity 
are expressed at time t, the individual constants gj and fk are scaled by 𝑋𝑔,𝑗(𝑡) and 𝑋𝑓,𝑘(𝑡), 
respectively, which are equal to 1 if j is susceptible at time t and if k is infectious at time t, 
respectively, and 0 otherwise. Similarly, individual recovery rates were assumed to be equal 
to 𝛾𝑗(𝑡)  =  𝑋𝑓,𝑗(𝑡)𝛾𝑗, with γj and 𝑋𝑓,𝑗(𝑡) as defined above. 
It was initially assumed that host susceptibility and infectivity were the only sources of 
individual variation. Thus, parameter γj was set equal to 0.1 for all individuals. For simplicity, 
it was further assumed that the expected number of contacts per unit time interval between 
two individuals in the same group was homogeneous and, without loss of generality, was set 
equal to 𝑐𝑗𝑘 = 1. This homogeneity assumption is likely to be satisfied in intensive farming 
conditions. The values of βjk(t) and γj(t) were calculated at each event time, starting from time 
zero. Based on these, Gillespie’s direct algorithm was used to determine the next event 
(infection or recovery), the time of the event and the affected individuals, as outlined in [3]. 
The simulation was run until the time t at which approximately 50% of individuals had 
become infected. 
In order to demonstrate that the derived probability function given by equations (14) and (15) 
is valid for a range of epidemiological models, binary disease data were also generated by 
simulating an epidemic using a stochastic SIR model with additional variation in recovery 
rate γ and a stochastic SLIRS model, following the same principles as described above. In a 
SLIRS model, the epidemiological compartments are: Susceptible (S), Latently infected but 
not infectious (L), Infectious (I), Recovered and temporarily immune (R), and Susceptible 
(S). The speed of transition between compartments S and L is given by βjk(t), as described 
above. Similarly, all other individual transition speeds were assumed equal to a constant 
value for individuals in the relevant compartment and 0 otherwise. Specifically, the constants 
were; 0.5 for L → I, 0.1 for I → R and 0.2 for R → S. Similar to the previous simulation, it 
was assumed that the expected number of contacts between two individuals per time unit 
𝑐𝑗𝑘 = 1 for all individuals from the same group. This simulation was run until the same value 
of t as above, which resulted in approximately 58% of individuals becoming infected. 
Thus, the different epidemiological models used for simulation were (i) a SIR model with 
host variation in susceptibility and infectivity only; (ii) a SIR model with host variation in 
susceptibility, infectivity and recovery rate; and (iii) a SLIRS model with host variation in 
susceptibility and infectivity only. 
Each model was run for a population of size N = 100 000 individuals, randomly divided into 
10 000 isolated groups of size 10 chosen, which is equivalent to simulating 10 000 
independent epidemics. Susceptibility and infectivity were assumed to be distributed 
according to a right-skewed gamma distribution Г(a,θ), which is representative for a variety 
of infectious diseases [16]. Moreover, skewed distributions allow for larger variation when 
the distribution is confined to positive values. For simplicity, susceptibility and infectivity 
were assumed to be independent. Similarly, additional individual variation in recovery rate 
was incorporated into the above described SIR model by sampling individual time to 
recovery 1/𝛾𝑗 from a right-skewed Gamma distribution Γ(2,5). In other words, it was 
assumed that most individuals recover quickly, that a few individuals may take a very long 
time to recover, and that the mean time to recovery was ten time units. This simulation was 
run until the same value of t as above, which resulted in approximately 41% of individuals 
becoming infected. 
Each epidemiological model provided the binary disease state (infected/ not infected by time 
t) for every individual as output. Furthermore, the period of time during which each 
individual remained infectious (Dk) was recorded for validation purposes. Note that the 
duration of the infectious period D in equation (15) captures individual variation in the 
transmission speeds between compartments LI, I R and RS. Knowledge of the 
infectious period, together with the known input values of c, g and f, allowed calculation of 
the quantity Λj(t) using equation (15) and hence the probability of becoming infected by a 
time t, based on equation (14). This was then compared with the observed proportion of 
individuals that became infected by time t in the simulations, within a given class of Λj(t). 
The class size for Λj(t) was taken as 0.02 to ensure that sufficient records were available 
within each class. 
Results 
Validation of the probability function 
Concordance with epidemiological theory 
We first demonstrate that for homogeneous populations, equations (14) and (15) are 
consistent with existing epidemiological theory and with the method of survival analysis. In a 
homogeneous population, i.e. when there is no variation in susceptibility (gj = g for each 
individual j), infectivity (fk = f for all k), contact rate (cjk = c for all j, k) or any of the other 
epidemiological parameters, equation (15) becomes 
Λ_𝑗 (𝑡)  = Λ(𝑡)  =   𝑐𝑔𝑓 � 𝐷𝑘(𝑡)𝑛
𝑘=1,𝑘≠ 𝑗 .  (17) 
Also, following equation (16), in the case of homogeneity, for any pair consisting of a 
susceptible individual j and an infectious individual k (i.e. Xg,j(t) = Xf,k(t) = 1), the 
transmission coefficient is 
𝛽 =  −𝑐𝑙𝑛(1 − 𝑔𝑓) ≈  𝑐𝑔𝑓,  (18) 
for small values of g and f. 
Furthermore, the sum of the infectious period of each individual in a group, within the time 
interval from 0 to t, can be written as 
� 𝐷𝑘(𝑡)𝑛
𝑘=1,𝑘≠ 𝑗  = � 𝐼(𝜏)𝑑𝜏,𝑡0  (19) 
where I(τ) denotes the number of infectious individuals at time τ. In an SIR model with 
constant recovery rate γ, the number of recovered individuals, R, changes over time 
according to 𝑑𝑅/𝑑𝑡 = 𝛾𝐼(𝑡), thus yielding the following for the above sum over infectious 
periods 
� 𝐷𝑘(𝑡)𝑛
𝑘=1,𝑘≠ 𝑗  = 1𝛾 𝑅(𝑡). (20) 
Note that in an SIR model, the basic reproductive ratio R0 is 
𝑅0 = 𝛽 𝑆0𝛾 , (21) 
where S0 is the number of susceptible individuals at the start of the epidemic [10]. 
Substituting equations (18) to (21) into (17), yields for Λj(t) = Λ(t) 
Λ(𝑡) =  𝑅0 𝑅(𝑡)
𝑆0
,  (22) 
and hence for Pj(t) = P(t) according to equation (14) 
𝑃(𝑡)  =  1 − 𝑒𝑥𝑝 �−𝑅0 𝑅(𝑡)
𝑆0
�.  
Hence, the expression for the probability of becoming infected derived, as in the paragraph 
“Epidemiological principles and approaches” for heterogeneous populations, i.e. equation 
(14), is consistent with equation (1) from epidemiological literature if there is no individual 
variation. 
The probability function (14) is also consistent with the notion of failure in survival analysis, 
where the failure function F(t) represents the probability of failure by time t and is defined as 
𝐹(𝑡) = 1 − 𝑒−Λ(𝑡), where Λ(t) is the cumulative hazard function [20]. In this context, failure 
represents becoming infected. Therefore, equation (14) can be considered a failure function 
with a cumulative hazard function given by equation (15). 
Function validation with simulated disease data 
Figure 1 shows the proportion of individuals that had become infected by time t in the 
epidemiological simulations, for a given time t and calculated values of Λj(t), as well as the 
analytical expression for the probability of becoming infected derived in equations (14) and 
(15). Figures 1a, b and c indicate that the probability function provides a good fit to the 
probability of becoming infected. Moreover, this function provides a robust fit across a range 
of epidemiological scenarios, as shown in Figures 1a, b and c for, respectively, the SIR model 
with variation in susceptibility and infectivity, with additional variation in recovery rate, and 
the SLIRS model. Note that parameter values used in the simulations (see the above 
paragraph “Derivation of a genetic-epidemiological probability function“) are arbitrary and 
not expected to affect the fit. 
Figure 1 Comparison of the probability function (equations (14) and (15)) with results 
from simulated disease data. For details regarding simulation parameters see paragraph 
“Derivation of a genetic-epidemiological probability function“; data points: proportion of 
infected individuals for a given class of Λj(t) using equation (15) with class size 0.02; curve: 
expected probability of becoming infected by time t following equations (14) and (15); 
panels: a. SIR model with variation in susceptibility and infectivity only, b. SIR model with 
variation in recovery rate, and c. SLIRS model. 
Figure 2 shows ROC curves for predicting whether an individual has become infected or not 
by time t, with the derived probability given by equations (14) and (15) as the classification 
criterion. According to Figure 2, the derived probability is effective at predicting whether an 
individual will become infected or not by time t, in a manner that is consistent with an 
accurate probability function, i.e. with an AUC that is close to, but not equal to, 1. Moreover, 
the predictive ability of the derived probability function is robust across a range of 
epidemiological scenarios, with an AUC between 96-97% for all simulations. 
Figure 2 ROC curves for predicting disease status using the probability function 
(equations (14) and (15)). Curves: green = data from simulation of the SIR model with 
variation in susceptibility and infectivity (AUC = 0.964); blue = data from simulation of SIR 
model with variation in susceptibility, infectivity and recovery rate (AUC = 0.960); brown = 
data from simulation of SLIRS model with variation in susceptibility and infectivity (AUC = 
0.970); black = random classification (AUC = 0.5); grey = perfect classification (AUC = 1). 
The probability function (14), with Λ(t) defined in (15), captures different sources of host 
(genetic) variation, which may not be easy to estimate in practice. In particular, whereas 
susceptibility g and infectivity f may harbour substantial genetic variation, the duration of the 
infectious period D within a given time interval are more likely to depend upon a 
combination of various genetic (e.g., g, f and also in γ) and environmental (e.g., choice of 
time interval), or other stochastic factors. In order to determine the importance of estimating 
these components of Λj(t) for predicting the future disease status of an individual, ROC 
curves were also generated with the classification criterion estimated by assuming either no 
(genetic) heterogeneity in g and f (i.e. calculating Λj(t) according to equation (17)), or by 
assuming genetic heterogeneity but equal non-dynamic exposure (𝐷𝑘(𝑡) = ?¯?  for each 
individual k) in the probability function. The first scenario may be considered to be in line 
with current epidemiological theory, as outlined in the above paragraph “Derivation of a 
genetic-epidemiological probability function“ (equation (17)), whereas the second scenario 
may be considered to be more in line with current quantitative genetics theory that ignores 
dynamic exposure. Note that exact values of Dk(t) may not be available from field data and, 
therefore, using the further approximation from equation (20) is more in line with current 
epidemiological practice. However, applying this approximation results in discrete values of 
Dk(t) rather than a continuous curve (results not shown). Nonetheless, the resulting discrete 
values are close to the curve obtained without using this approximation. Figure 3 shows a 
comparison of the ROC curves that correspond to these ‘epidemiological’ and ‘genetic’ 
assumptions, with the ROC curve that combines genetics and epidemiology in the derived 
expression for Λj(t) outlined in equation (15). The ROC curves in Figure 3 reveal that 
quantifying the exposure over time explains most of the ability to predict whether an 
individual will become infected or not. Furthermore, predictions of an individual’s disease 
status are considerably improved when all sources of genetic and epidemiological variation 
are included in the calculations. 
Figure 3 Effect of including different sources of host variation on the prediction of 
individual disease status. ROC curves calculated with data from simulation of the SIR 
model with variation in susceptibility and infectivity; the classification criterion used was the 
probability function equation (14) with Λjt including different sources of variation; curves in 
green = ‘Genetic epidemiology’ - Λjt includes all sources of variation and was estimated 
based on equation (15) (AUC = 0.964); orange = ‘Epidemiology’ - Λjt was estimated 
assuming no (genetic) variation in susceptibility and infectivity, as in equation (17) (AUC = 
0.895); purple = ‘Genetics’ - Λjt was estimated assuming (genetic) variation in susceptibility 
and infectivity, but equal non-dynamic exposure, i.e. Dk(t) = D¯ for each individual k (AUC = 
0.710); black = random classification (AUC = 0.5); grey = perfect classification (AUC = 1). 
Discussion 
Extension to current epidemiological and quantitative genetics theories 
Using mathematical principles, a genetic – epidemiological probability function was derived 
that links binary disease data to the underlying epidemiological traits, host susceptibility and 
infectiousness. The function is an extension of the established epidemiological equation for 
the probability of becoming infected by a time t (1) from homogeneous to heterogeneous 
populations. Indeed, in line with epidemiological theory, the quantity Λj(t) described in 
equation (15) may be called the individual force of infection of an individual j at time t. 
Defining infectiousness of individual k towards individual j until time t as the product 
ϕ𝑗𝑘(𝑡) =  𝑐𝑗𝑘𝑓𝑘𝐷𝑘(𝑡), as previously postulated by Lloyd-Smith et al. [9], simplifies the 
expression for Λj(t) to: 
Λ𝑗(𝑡)   =  𝑔𝑗  � ϕ𝑗𝑘(𝑡).𝑛
𝑘=1,𝑘≠ 𝑗   (23) 
Thus, the force of infection for an individual j is the product of the individual’s susceptibility 
and the cumulative infectiousness of its group members towards it, which reflects that an 
infectious disease results from interactions between susceptible and infectious individuals. 
Note that under the assumption that 𝑐𝑗𝑘 = 𝑐𝑘 for each individual k, the infectiousness 𝜙𝑗𝑘(𝑡) 
derived here corresponds to the individual reproductive number with population mean R0, as 
defined in epidemiological literature [9]. In the context of quantitative genetics, the 
cumulative infectiousness replaces the concept of exposure. Rather than an equal, constant 
and purely environmental exposure, as is typically assumed [5], the individual force of 
infection in equation (23) illustrates that exposure depends on the number of infectious 
individuals, which may change over time as their infection status changes, as well as on their 
contact behaviour and infectivity, where some or all of these components may be partly 
genetically determined. In particular, the time Dk(t) during which an individual remains 
infected may be partly genetically determined since it encapsulates several mechanisms that 
are determined by the immune system, such as recovery and latency. Thus, there is 
potentially much to be gained by incorporating epidemiological information into genetic 
analyses, and vice-versa, as illustrated in Figure 3. 
The concept that an individual’s phenotype is not only controlled by its own genes but also 
by the genes of interacting individuals is not new in quantitative genetics, and has already 
been successfully incorporated in the form of indirect (or associative) genetics effect (IGE) 
models [20-22]. We have previously applied such IGE models to estimate genetic parameters 
associated with host susceptibility and infectivity from simulated binary disease data [3,4], 
and found that IGE models can indeed capture some of the genetic variation underlying 
infectiousness. However, we have also found use of the current IGE framework in the context 
of infectious disease to have shortcomings since crucial dynamic aspects are ignored, which 
leads to bias in parameter estimates [4]. As outlined in more detail below, the derived 
genetic-epidemiological probability function offers a means to extend the current IGE model 
framework to infectious diseases in populations that display genetic variation in diverse 
epidemiological traits for which expression varies throughout the time course of infection. 
Implementation of the probability function into quantitative genetic analysis 
In order to incorporate susceptibility and infectiousness into genetic selection programs, 
knowledge of the respective genetic (co)variances is required. Moreover, it might be 
desirable to use estimated breeding values of these traits for genetic selection or for genome-
wide association studies. Estimation of breeding values by best linear unbiased prediction 
requires not only knowledge of the genetic variance [2] but also the use of mixed models, as 
these allow simultaneous estimation of fixed effects and random genetic effects [2]. 
Susceptibility and infectiousness are difficult to measure directly and, as was assumed in this 
paper, field disease data is often binary, indicating whether an individual became infected or 
not. It is customary to use a generalized linear (mixed) model (GL(M)M) to analyse binary or 
categorical data [23]. In such models, the observed trait is linked to an assumed linear model 
of the underlying continuous trait(s) via a non-linear link function. Canonical link functions 
that are commonly used for binary data are the probit and logit link functions [23], which 
assume that the probability of the trait to be equal to one, i.e. to have become infected in our 
case, follows a cumulative normal or a logistic distribution, respectively [23]. Despite their 
convenient mathematical properties, neither distribution, however, arises naturally from 
epidemiological theory, as demonstrated in the present study. A consequence of this is that 
interpretation of such analyses in terms of epidemiological parameters is problematic at best. 
A suitable link function for a GL(M)M transforms the observed trait into a linear expression 
of the parameters of interest. However, in the genetic epidemiological probability function 
Pj(t) (equation (14) with Λj(t) defined in equation (23)), the parameters of interest, i.e. the 
epidemiological traits susceptibility and infectiousness, enter in a multiplicative rather than in 
a linear manner. However, if there was genetic variation in susceptibility only, it follows from 
equations (14) and (23) that the probability Pj(t) can be linked to the following linear model 
in susceptibility using a complementary log-log link function: 
ln �Λ𝑗(𝑡)�   = ln�𝑔𝑗�  + ln� � ϕ𝑗𝑘(𝑡)𝑛
𝑘=1,𝑘≠ 𝑗  �. (24) 
Assuming no genetic variation in the epidemiological traits cjk, fk and Dk that underlie 
infectiousness, the second summand of equation (24) can be considered to be an error term 
ej(t). However, in contrast to using the canonical logit and probit link functions, this model 
captures and completely separates the individual’s susceptibility from the dynamic aspects of 
exposure. 
However, when there is genetic variation in both susceptibility and infectiousness, it is not 
straightforward to link the probability Pj(t) of becoming infected to a linear model that 
includes both susceptibility and infectiousness. Indeed, the complementary log-log link 
function (24) is no longer adequate when there is variation in infectiousness since the 
logarithm of a sum does not equal the sum of the logarithms. It is, however, possible to 
linearize the force of infection from equation (23), in both susceptibility and infectiousness, 
using e.g. the Taylor series expansion of Λ𝑗(𝑡) =  𝑔𝑗  ∑ 𝜙𝑘(𝑡)𝑛𝑘=1,𝑘≠ 𝑗  near the population 
mean susceptibility ?¯? and the population mean infectiousness ?¯?(𝑡)  up to time t: 
Λj(𝑡) = (𝑛 − 1)?̅? 𝜙�(𝑡) + (𝑛 − 1)𝜙�(𝑡)�𝑔𝑗 − ?̅?�  +?̅? � �𝜙𝑗𝑘(𝑡) − 𝜙�(𝑡)�𝑛
𝑘=1,𝑘≠ 𝑗   +�𝑔𝑗 − ?̅? � � (𝜙𝑗𝑘 (𝑡) − 𝜙�(𝑡))𝑛
𝑘=1,𝑘≠ 𝑗   
(25) 
Note that the Taylor series of Λj(t) in equation (25) is not truncated and that it includes only 
one non-linear term in susceptibility and infectiousness. Following a GL(M)M framework, if 
the last term of equation (25) was negligible, the expression for Λj(t) would be linear and thus 
an appropriate link between observed binary disease data (infected or not infected) and the 
underlying epidemiological traits, host susceptibility and infectiousness. 
Note that truncating equation (25) after the linear terms in gj and 𝜙𝑗𝑘(𝑡) corresponds to an 
IGE model for the individual force of infection Λj(t). IGE models describe the phenotype Pj 
(here Pj = Λj(t)) of an individual j as a linear combination of the individual’s direct effect PDj, 
and the cumulate indirect (or associative) effect PSk of its group members, i.e. 
𝑃𝑗(𝑡)  = 𝜇 +  𝑃𝐷𝑗  + � 𝑃𝑆𝑘 ,𝑛
𝑘=1,𝑘≠ 𝑗  (26) 
with an underlying genetic component for both the direct and indirect effects and with μ 
denoting the population mean phenotype, e.g. [20,21]. The connection between host 
infectiousness and indirect effects has been established previously [3] but the exact nature of 
this connection was unknown. Thus, comparison of the linear part of equation (25) with 
equation (26) offers a new interpretation of direct and indirect effects in this context and of 
previous results. Indeed, according to equation (25), the direct effect corresponds to the 
susceptibility of individual j (expressed as deviation from the population mean susceptibility), 
scaled by the cumulative average infectiousness of the group members up to time t, and the 
indirect (or associative) effect of a group member corresponds to its infectiousness (expressed 
as deviation from the population mean infectiousness until time t), scaled by the average 
population susceptibility. Furthermore, equation (25) may shed some light on potential causes 
for the previously observed bias in the genetic parameter estimates in infectivity [4]. This 
bias may have resulted from the inadequacy of the linear and logit models used in the 
previous analyses, as neither emerges from epidemiological theory and the appropriate link 
function was yet unknown. Furthermore, as illustrated in equation (25), the non-linear 
interaction between susceptibility and infectiousness may become non-negligible if there are 
large deviations in infectiousness ϕ from the population mean. This is illustrated in Figure 4, 
which shows the ROC curves with the classification criterion estimated with the full (AUC = 
0.964) and truncated (AUC = 0.751) versions of equation (25). In other words, in the 
presence of super-spreaders, i.e. highly infectious individuals, the use of a GL(M)M or any 
other linear framework is likely to create bias. For the purpose of identifying super-spreaders, 
it would therefore be desirable to develop computational algorithms that do not require linear 
approximations of the force of infection function. Such non-linear algorithms would also be 
needed to disentangle the individual components of infectiousness, e.g. to separate genetic 
variation in the ability to transmit the infection upon exposure (i.e. variation in f) from 
genetic variation in the duration of the infectious period (i.e. variation in D). These sources of 
variation likely correspond to different immunological processes (e.g. shedding vs. recovery) 
and may therefore be controlled by different sets of genes. However, separating 
infectiousness components in genetic analyses may come with additional data requirements. 
For example, repeated binary measurement of an individual’s disease status over time rather 
than one single snapshot in time may be required to infer genetic variation in the duration of 
the infectious period. These measurements may be taken from on-going epidemics by using 
equation (13) instead of (14), with Pj(0) equal to the prevalence of the disease in the first 
observation. Markov Chain Monte Carlo methods [24], with their hierarchical iterative 
sampling process, appear well suited to incorporate the dynamic expression of host 
susceptibility and infectiousness. Such methods may also lend themselves more easily to the 
consideration of other uncertainties that frequently affect observed disease phenotypes, such 
as incomplete sensitivity or specificity of diagnostic tests. 
Figure 4 ROC curve for predicting disease status using an IGE model. Data from 
simulation of the SIR model with variation in susceptibility and infectivity; curves in green = 
the probability function with lambda estimated as in equation (15) used as classification 
criterion (AUC = 0.964); brown (overlapping with green curve) = the probability function 
with lambda estimated using the Taylor expansion from equation (25) used as classification 
criterion (AUC = 0.964); purple = an IGE model (equation (26)) used as classification 
criterion (AUC = 0.751); black = random classification; grey = perfect classification. 
Conclusions 
We have derived a genetic epidemiological function for quantitative genetic analyses of 
binary infectious disease data that takes genetic variation and the dynamic expression of host 
infectiousness into account. The function describes the probability of an individual to become 
infected given its own susceptibility and the infectiousness of its group mates. When 
variation is limited to host susceptibility, it is possible to estimate genetic variation for this 
trait in a manner compatible with epidemiological dynamics using the complementary log-log 
link function. When there is genetic variation in both susceptibility and infectiousness, it is 
possible to use the logarithmic link function with a linear IGE model but this is likely to 
generate prediction bias if there is a large variation in infectiousness. Future work will 
concentrate on developing computational algorithms that can incorporate the genetic 
epidemiological function without linear approximations, in order to identify potential genetic 
super-spreaders. These algorithms would enable us to uncover the genetics underlying 
epidemics and thus shape the epidemics of tomorrow. 
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